Chris Schott analyst JPMORGAN

Currently out of the existing stock ratings of Chris Schott, 227 are a BUY (67.16%), 98 are a HOLD (28.99%), 13 are a SELL (3.85%).

Chris Schott

Work Performance Price Targets & Ratings Chart

Analyst Chris Schott, currently employed at JPMORGAN, has had 53.46% of price targets met with an average potential upside of 27.61%, reached in 341 days on average.

Chris Schott has documented 657 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ELAN, Elanco Animal Health at 09-Nov-2026.

Wall Street Analyst Chris Schott

Analyst best performing recommendations are on EQRX (EQRX).
The best stock recommendation documented was for EQRX (EQRX) on 8/16/2022. The price target of $5.5 was fulfilled within 3 days with a profit of $0.67 (13.87%), with a performance score of 46.24.

Average potential price target upside

ABBV AbbVie BHC Bausch Health Companies BMY Bristol-Myers Squibb Company HZNP Horizon Pharma PLC IDXX IDEXX Laboratories JNJ Johnson & Johnson LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer TEVA Teva Pharma Industries Ltd ADR ELAN Elanco Animal Health HSKA Heska MYL Viatris AGN Allergan plc CHRS Coherus BioSciences MNK Mallinckrodt plc RPRX Royalty Pharma Plc VTRS Viatris EQRX EQRx ZTS Zoetis ENDP Endo International PLC PRGO Perrigo Company PLC REGN Regeneron Pharmaceuticals TXMD TherapeuticsMD KALA Kala Pharmaceuticals OGN Organon PCRX Pacira Pharmaceuticals BIIB Biogen AMRX Amneal Pharmaceuticals GILD Gilead Sciences AMGN Amgen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Nov-2020

$338

$42.97 (14.56%)

$282

14 days ago
(02-Nov-2026)

20/21 (95.24%)

$43.11 (14.62%)

335

Buy Since 05-Feb-2020

$322

$26.97 (9.14%)

$288

14 days ago
(02-Nov-2026)

45/46 (97.83%)

$27.11 (9.19%)

407

Buy Since 08-Dec-2021

$340

$44.97 (15.24%)

$300

14 days ago
(02-Nov-2026)

11/13 (84.62%)

$45.11 (15.30%)

479

Buy Since 02-Nov-2026

$342

$46.97 (15.92%)

$206

14 days ago
(02-Nov-2026)

19/20 (95%)

$47.11 (15.98%)

376

Buy Since 25-Feb-2026

$330

$34.97 (11.85%)

$280

14 days ago
(02-Nov-2026)

7/8 (87.5%)

$35.11 (11.91%)

173

Show more analysts

Please expand the browser size to see the chart

Which stock is Chris Schott most bullish on?

Potential upside of $56.5 has been obtained for LLY (ELI LILLY AND COMPANY)

Which stock is Chris Schott most reserved on?

Potential downside of -$40.67 has been obtained for AMGN (AMGEN)

What Year was the first public recommendation made by Chris Schott?

On 2009
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?